Results 71 to 80 of about 601 (148)

Key role of Levitt's carbon monoxide breath test in revealing coexistent Gilbert syndrome and erythropoietic protoporphyria: A case report. [PDF]

World J Clin Cases
Kang LL, Zhang HD.
europepmc   +1 more source

Congenital Erythropoietic Porphyria with Persistent Severe Biochemical Abnormalities and a Non-Mutilating Clinical Course: A Case Report. [PDF]

Reports (MDPI)
Peshin S, Takrori E, Khan KS, Rahimuddin B, Upadhyaya SK, Gami PK, Singal S.   +6 more
europepmc   +1 more source

Acute Protoporphyric Hepatopathy as the Initial Presentation of Erythropoietic Protoporphyria in Adulthood. [PDF]

ACG Case Rep J
Alsaleh T, Mohammed A, Karnam M, Roman T.   +3 more
europepmc   +1 more source

From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria. [PDF]

JAAD Case Rep
Minder AE, Barman-Aksözen J.
europepmc   +1 more source

04107 The EPP LIGHT Study: understanding the burden of erythropoietic protoporphyria (EPP) from the patient perspective

Poster 22
Hetanshi Naik, Kristen Wheeden, Susan D Mathias, Chelsea Norregaard, Hilary H Colwell, Melanie Chin, William Savage, Manisha Balwani   +7 more
openaire   +1 more source

Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis. [PDF]

J Manag Care Spec Pharm
DerSarkissian M, Norregaard C, Romdhani H, Muthukumar A, Bobbili P, Chin M, Liu W, Trinh L.   +7 more
europepmc   +1 more source

04109 The impact of erythropoietic protoporphyria (EPP) on family quality of life

Poster 61
LL Griffin, R Sarkany, D Schulenburg-Brand, C Rowland, LE Rhodes, MD Farrar   +5 more
openaire   +1 more source

04191 Inhibition of glycine transporter 1 reduces EPP phototoxicity in a mouse model of erythropoietic protoporphyria (EPP)

Poster 1
Yi Xiang, Yue Chen, Scott Reisman, Srikanth Venkatraman, Hua Yang, Brian MacDonald, Min Wu   +6 more
openaire   +1 more source

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists. [PDF]

Hepatol Commun
Ricci A, Corradini E, Buzzetti E, Pietrangelo A, Pietrangelo A, Ventura P, Modena Centre of Rare Diseases - Porphyria Working Group.   +6 more
europepmc   +1 more source

New pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective. [PDF]

Orphanet J Rare Dis
Dechant C, Wäscher S, Granata F, Gusset N, Pettersson M, Aksözen MH, Höglinger M, Falchetto R, Barman-Aksözen J.   +8 more
europepmc   +1 more source